Iowa Admin. Code r. 657-8.21

Current through Register Vol. 47, No. 11, December 11, 2024

Rule 657-8.21 - Prospective drug use review

(1) For purposes of promoting therapeutic appropriateness and ensuring rational drug therapy, a pharmacist shall review the patient record, information obtained from the patient, and each prescription drug or medication order to identify:

a. Overutilization or underutilization;

b. Therapeutic duplication;

c. Drug-disease contraindications;

d. Drug-drug interactions;

e. Incorrect drug dosage or duration of drug treatment;

f. Drug-allergy interactions;

g. Clinical abuse/misuse;

h. Drug-prescriber contraindications.

Upon recognizing any of the above, the pharmacist shall take appropriate steps to avoid or resolve the problem and shall, if necessary, include consultation with the prescriber. The review and assessment of patient records shall not be delegated to pharmacy technicians or pharmacy support persons but may be delegated to registered pharmacist-interns under the direct supervision of the pharmacist.

(2) A pharmacist shall be exempt from the requirements of subrule 8.21(1) when dispensing a prescription issued to an unnamed patient for an oral antibiotic pursuant to Iowa Code section 139A.41.

Iowa Admin. Code r. 657-8.21

Amended by IAB June 20, 2018/Volume XL, Number 26, effective 7/25/2018

Amended by IAB February 12, 2020/Volume XLII, Number 17, effective 3/18/2020